Latest News & Updates

Breaking News

  • 9 hours ago

  • Simantini Singh Deo

COSCIENS Biopharma Appoints Chairman Peter H. Puccetti, CFA, As Interim CEO Following Anna Biehn’s Departure
Breaking News
Biogen Completes Acquisition Of Alcyone Therapeutics, Bringing ThecaFlex DRx™ CNS Drug-Delivery Technology Into Its Neurology Portfolio

Simantini Singh Deo

Other trending news you may like to read

COSCIENS Biopharma Appoints Chairman Peter H. Puccetti, CFA, As Interim CEO Following Anna Biehn’s Departure

COSCIENS Biopharma appoints Peter H. Puccetti as Interim CEO amid ongoing restructuring efforts.

Simantini Singh Deo

Pharma Now

Biogen Completes Acquisition Of Alcyone Therapeutics, Bringing ThecaFlex DRx™ CNS Drug-Delivery Technology Into Its Neurology Portfolio

Biogen acquires Alcyone, adding ThecaFlex DRx to enhance intrathecal delivery for neurological therapies.

Simantini Singh Deo

Pharma Now

Bry-Air Launches P80x: The Most Advanced Dehumidifier Based on MOF technology, for the Pharmaceutical Industry

Bry-Air debuts P80x MOF-based dehumidifier, offering high performance and major energy savings for pharma facilities.

Team Pharma Now

Pharma Now

Medicus Pharma Gains UK Approval to Expand Phase 2 Trial Of Doxorubicin Microneedle Therapy for Basal Cell Carcinoma

Medicus Pharma secures UK approvals to expand its Phase 2 trial of its non-invasive Doxorubicin Microneedle Array for treating basal cell carcinoma.

Vaibhavi M.

Pharma Now